CSRXP: 117TH CONGRESS TAKES FIRST STEP ON LOWERING PRESCRIPTION DRUG PRICES, HOLDING BIG PHARMA ACCOUNTABLE
Lawmakers Pass Pair of Bills Aimed at Boosting Generic and Biosimilar… Read More
Lawmakers Pass Pair of Bills Aimed at Boosting Generic and Biosimilar… Read More
Campaign Will Highlight Impact of Out-of-Control Drug Prices, Especially in… Read More
Government Report Finds No Relationship Between Drug Company R&D and… Read More
Legislation Will Boost Transparency to Hold Big Pharma Accountable for… Read More
Campaign Looks Forward to Working with Secretary Becerra to Lower Drug Prices… Read More
Big Pharma CFO Hypes “Significant Opportunity” From “Pricing… Read More
Big Pharma Has Already Repeatedly Hiked Drug Prices During Public Health… Read More
Resource Provides Information on Out-of-Control Drug Prices — Outlines… Read More
HHS Pause of Misguided, Pharma-Backed Policy Will Help Refocus Attention on… Read More
Clear Majority of Voters Identify Rx Drug Affordability as Top Issue and… Read More
Investigation Will Shed Light On Big Pharma’s Price Hikes During Public… Read More
Bipartisan Investigation Details How Drug Companies Work in Tandem to Hike… Read More